| 1 |
29799059 | Questionnaire survey on adjuvant chemotherapy for elderly patients after gastrectomy indicates their vulnelabilities. | 2019 Jan |
1 |
| 2 |
30713297 | A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102. | 2019 May 15 |
1 |
| 3 |
25874010 | Risk factors for discontinuation of s-1 adjuvant chemotherapy for gastric cancer. | 2015 |
1 |
| 4 |
24090674 | Phase II study of S-1 monotherapy in patients over 75 years of age with advanced gastric cancer (OGSG0404). | 2014 Feb |
1 |
| 5 |
25297990 | Risk factors for 6-month continuation of S-1 adjuvant chemotherapy for resected pancreatic cancer. | 2014 Dec |
1 |
| 6 |
22527186 | Risk factors for 6-month continuation of S-1 adjuvant chemotherapy for gastric cancer. | 2013 Apr |
2 |
| 7 |
23066919 | Safety, compliance, and predictive parameters for dosage modification in adjuvant S-1 chemotherapy for gastric cancer. | 2013 Jan |
1 |
| 8 |
22902443 | [Examination of factors influencing continuity of S-1 adjuvant chemotherapy for gastric cancer patients]. | 2012 Aug |
1 |
| 9 |
19727730 | Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study. | 2010 May |
1 |
| 10 |
20495311 | [Continuous administration and safety of S-1 in adjuvant chemotherapy for gastric cancer]. | 2010 May |
1 |